New research reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt traditional diet and exercise plans.
Findings released in a leading medical journal shows that while overweight people frequently drop a large proportion of their total mass while using the jabs, the mass comes back at an average rate of nearly a kilo each month after stopping.
"People purchasing these treatments need to be cognizant of the potential of quick rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
That rate of recovery means a return to starting mass in about a year and a half.
Comparing Treatments
The study, which reviewed dozens of studies involving thousands of patients, contrasted the results of these new drugs with older methods.
Scientists note that individuals who lose weight through dieting usually experience a more gradual weight regain—around 0.1 kg a month—once they finish.
Explaining the Fast Rebound
Nutrition scientists suggest the way of the jabs accounts for the accelerated rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 levels far above than normal could lead to the body to produce less of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines recommend the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals contend that, due to the high risk of relapse, the treatment might need to be ongoing.
This view is echoed by drug manufacturers, who note that the results "emphasize the chronic nature of obesity," comparing it to managing conditions like hypertension.
User Experiences
Users who have come off the medication describe a sudden return of cravings.
"I experienced a trigger activating and you become ravenous," said an individual.
This difficulty is worsened if individuals have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Interest
Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is higher among females than males.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Finally, experts caution that while these medications are potent agents for weight loss, they are not a permanent cure and long-term success hinges on integrated behavioural support.
